All News #Library
Enforcement Report - Week of May 24, 2023
24 May 2023 //
FDA
Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs
15 Jun 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sanofi-Aventis` Avapro
14 Jun 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sanofi-Aventis` Avalide
14 Jun 2021 //
HEALTH CANADA
Health Canada Issues Recalls of Bausch Health, Canada`s Rifampin
17 Mar 2020 //
HEALTH CANADA
Enforcement Report - Week of December 11, 2019
11 Dec 2019 //
FDA
Health Canada Issues Recall of Sanofi-Aventis Canada Nasacourt Allergy 24 hr
10 Aug 2019 //
HEALTH CANADA
Health Canada Recalls Nasacort Allergy 24-Hr
23 Nov 2018 //
HEALTH CANADA
Enforcement Report - Week of July 18, 2018
18 Jul 2018 //
FDA
Enforcement Report - Week of January 17, 2018
17 Jan 2018 //
FDA
Enforcement Report - Week of November 22, 2017
22 Nov 2017 //
FDA
Enforcement Report - Week of November 8, 2017
08 Nov 2017 //
FDA
Sanofi Pasteur Issues Recall of Typhim Vi Solution for Injection
01 Sep 2017 //
HEALTH CANADA
Enforcement Report - Week of July 5, 2017
05 Jul 2017 //
FDA
Enforcement Report - Week of May 17, 2017
17 May 2017 //
FDA
US FDA Enforcement Report- 1/June/2016
31 May 2016 //
FDA
Anvisa suspends lot of Thyrogen medicine
25 Feb 2016 //
ANVISA
Sanofi-aventis Canada recalls all lots of Allerject Due to Potential Inaccurate Dosage Delivery
28 Oct 2015 //
HEALTH CANADA
Anvisa suspends distribution of Sanofi –Aventis’ Antihypertensive Drug
08 Apr 2015 //
ANVISA
Sanofi recalls Enoxaparin Sodium injections in UK
03 Apr 2015 //
GOV.UK

Market Place
Sourcing Support